[HTML][HTML] Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I-definition, epidemiology, etiopathogenesis, clinical expression and management of the …

…, G Bossi, S Buonuomo, F Cardinale, E Cortis… - Italian Journal of …, 2018 - Springer
The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to
contribute to prompt diagnosis and appropriate treatment on the basis of different specialists’ …

[PDF][PDF] Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and …

…, P Quartier, P Berquin, S Certain, E Cortis… - The American Journal of …, 2002 - cell.com
Chronic infantile neurological cutaneous and articular (CINCA) syndrome is a severe
chronic inflammatory disease of early onset, characterized by cutaneous symptoms, central-…

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: report of forty‐six patients from an international multicenter series

…, MAJ Van Rossum, E Cortis… - Arthritis & …, 2011 - Wiley Online Library
Objective To examine the safety and efficacy of the interleukin‐1 (IL‐1) receptor antagonist
anakinra as first‐line therapy for systemic juvenile idiopathic arthritis (JIA). Methods Patients …

Covid-19 in children: A brief overview after three months experience

…, L Cristiani, E Mancino, R Nenna, E Cortis… - Paediatric Respiratory …, 2020 - Elsevier
Severe Acute Respiratory Syndrome – Coronavirus – 2 (SARS-CoV-2) and its related
Coronavirus Disease – 19 (COVID-19) has become a health emergency worldwide. The medical …

[HTML][HTML] Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease

…, A Taddio, P Palma, M El Hachem, E Cortis… - Italian Journal of …, 2021 - Springer
Aim of these revised recommendations for the general management of Kawasaki disease is
to encourage its prompter recognition and warrant the most appropriate therapy, based on …

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis

…, S Magni-Manzoni, A Insalaco, E Cortis… - …, 2010 - academic.oup.com
Objective. Macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic
arthritis (SoJIA) is considered to be an acquired form of familial haemophagocytic …

Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

…, M Bandeira, F Zulian, V Baca, E Cortis… - Arthritis Care & …, 2010 - Wiley Online Library
Longâ•’term outcome and prognostic factors of juvenile dermatomyositis: A multinational,
multicenter study of 490 patients Page 1 Long-Term Outcome and Prognostic Factors of …

Differentiating PFAPA syndrome from monogenic periodic fevers

…, A Meini, M Cattalini, S Federici, F Zulian, E Cortis… - …, 2009 - publications.aap.org
OBJECTIVES: To analyze whether there were clinical differences between genetically
positive and negative patients fulfilling periodic fever, aphthous stomatitis, pharyngitis, and …

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients

…, S Bordasco, M Vivarelli, B Ruggiero, E Cortis… - …, 2010 - academic.oup.com
Objectives. Toll-like receptor 9 (TLR9), which recognizes hypomethylated DNA [cytosine-phosphate-guanine
(CpG)], plays a role in the maintenance of serological memory and has …

Abnormal production of tumor necrosis factor (TNF)--alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected].

E Cortis, F De Benedetti, A Insalaco… - The Journal of …, 2004 - europepmc.org
We report a family with pyogenic sterile arthritis, pyoderna and acne syndrome (PAPA). The
proband presented several episodes of sterile pyogenic arthritis and became unresponsive …